A1ZN34:BVMF
Astrazeneca Plc Bdr
R$140,72
arrow_downward
-0,84%(-1,19) 1D
16 Okt., 10:46:48 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1ZN34...
Open
R$143,33
High
R$143,33
Low
R$140,72
Mkt. cap
260,98 mjd
Avg. vol.
892,00
Volume
8,00
52-wk high
R$190,40
52-wk low
R$129,06
Shares outstanding
1,55 mjd
No. of employees
96 k
Open
R$143,33
High
R$143,33
Low
R$140,72
Mkt. cap
260,98 mjd
Avg. vol.
892,00
Volume
8,00
52-wk high
R$190,40
52-wk low
R$129,06
Shares outstanding
1,55 mjd
No. of employees
96 k
News stories
From web sources and news partners
Traders Union
·
6 uur gelede
AstraZeneca shares technical analysis: Upward price move confirms strong near-term momentum
JournalArta
·
12 uur gelede
AstraZeneca Stock Analysis: Gains 3.24%, Testing Key Resistance
Reuters
·
15 uur gelede
AstraZeneca strikes $40 million AI drug discovery deal with insitro
Fox Business
·
18 uur gelede
AstraZeneca, Insitro strike AI drug discovery deal
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About Astrazeneca Plc Bdr
CEOPascal Soriot
Employees96,1 k
Founded06 Apr. 1999
HeadquartersCambridge, Cambridgeshire, Verenigde Koninkryk
SectorPharmaceutical industry
Websiteastrazeneca.com